Glyxambi 5 MILLIGRAM/1 TABLET, 25 MILLIGRAM/1 TABLET

Land: Jordanië

Taal: Engels

Bron: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Werkstoffen:

Linagliptin 5 MILLIGRAM/1 TABLET, Empagliflozin 25 MILLIGRAM/1 TABLET

Beschikbaar vanaf:

شركة مستودع الادوية العربي - THE ARAB DRUG STORE P.S.C

ATC-code:

A10BD19

INN (Algemene Internationale Benaming):

Linagliptin 5 MILLIGRAM/1 TABLET, Empagliflozin 25 MILLIGRAM/1 TABLET

Dosering:

5 MILLIGRAM/1 TABLET, 25 MILLIGRAM/1 TABLET

Eenheden in pakket:

30 TABLET

Geproduceerd door:

BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG(BIBERACCH)/GERMANY (المانيا)

Product samenvatting:

49.14 :سعر الجمهور + الضريبة

Bijsluiter

1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
GLYXAMBI
®
10 MG/5 MG FILM-COATED TABLETS
GLYXAMBI
® 25 MG/5 MG FILM-COATED TABLETS
empagliflozin/linagliptin
Read all of this leaflet carefully before you start taking this
medicine because it contains important
information for you.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Glyxambi is and what it is used for
2.
What you need to know before you take Glyxambi
3.
How to take Glyxambi
4.
Possible side effects
5.
How to store Glyxambi
6.
Contents of the pack and other information
1.
WHAT GLYXAMBI IS AND WHAT IT IS USED FOR
WHAT GLYXAMBI IS
Glyxambi contains two active substances called empagliflozin and
linagliptin. Each belongs to a group
of medicines called “oral anti-diabetics”. These are medicines
taken by mouth to treat type 2 diabetes.
WHAT IS TYPE 2 DIABETES?
Type 2 diabetes is a condition that comes from both your genes and
your lifestyle. If you have type 2
diabetes, your pancreas may not make enough insulin to control the
level of glucose in your blood, and
your body is unable to use its own insulin effectively. This results
in high levels of sugar in your
blood, which can lead to medical problems like heart disease, kidney
disease, blindness, and poor
circulation in your limbs.
HOW GLYXAMBI WORKS
Empagliflozin belongs to a group of medicines called sodium glucose
co-transporter-2 (SGLT2)
inhibitors. It works by blocking the SGLT2 protein in your kidneys.
This causes blood sugar (glucose)
to be removed in your urine. Linagliptin works in a different way,
namely by enabling the pancreas to
produce more insulin to lower blood glucose levels